Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
João EC, Morrison RL, Shapiro DE, Chakhtoura N, Gouvèa MIS, de Lourdes B Teixeira M, Fuller TL, Mmbaga BT, Ngocho JS, Njau BN, Violari A, Mathiba R, Essack Z, Pilotto JHS, Moreira LF, Rolon MJ, Cahn P, Prommas S, Cressey TR, Chokephaibulkit K, Werarak P, Laimon L, Hennessy R, Frenkel LM, Anthony P, Best BM, Siberry GK, Mirochnick M. João EC, et al. Among authors: chokephaibulkit k. Lancet HIV. 2020 May;7(5):e322-e331. doi: 10.1016/S2352-3018(20)30038-2. Lancet HIV. 2020. PMID: 32386720 Free PMC article. Clinical Trial.
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women.
Cressey TR, Van Dyke R, Jourdain G, Puthanakit T, Roongpisuthipong A, Achalapong J, Yuthavisuthi P, Prommas S, Chotivanich N, Maupin R, Smith E, Shapiro DE, Mirochnick M; IMPAACT P1032 Team. Cressey TR, et al. Antimicrob Agents Chemother. 2009 May;53(5):2189-91. doi: 10.1128/AAC.01091-08. Epub 2009 Feb 23. Antimicrob Agents Chemother. 2009. PMID: 19237646 Free PMC article.
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.
Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M; IMPAACT P1026s Team. Cressey TR, et al. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):245-52. doi: 10.1097/QAI.0b013e31823ff052. J Acquir Immune Defic Syndr. 2012. PMID: 22083071 Free PMC article. Clinical Trial.
Developmental pharmacokinetic changes of Lamivudine in infants and children.
Tremoulet AH, Nikanjam M, Cressey TR, Chokephaibulkit K, McKinney R, Mirochnick M, Capparelli EV. Tremoulet AH, et al. Among authors: chokephaibulkit k. J Clin Pharmacol. 2012 Dec;52(12):1824-32. doi: 10.1177/0091270011426563. Epub 2011 Dec 16. J Clin Pharmacol. 2012. PMID: 22180560 Free PMC article. Clinical Trial.
Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J; ACTG 5190/PACTG 1054 Study Team. Nielsen-Saines K, et al. Pediatrics. 2012 Jun;129(6):e1525-32. doi: 10.1542/peds.2011-2340. Epub 2012 May 14. Pediatrics. 2012. PMID: 22585772 Free PMC article. Clinical Trial.
Treatment Outcomes of Third-line Antiretroviral Regimens in HIV-infected Thai Adolescents.
Prasitsuebsai W, Sophonphan J, Chokephaibulkit K, Wongsawat J, Kanjanavanit S, Kosalaraksa P, Ngampiyakul C, Sangkla P, Hansudewechakul R, Kerr SJ, Puthanakit T, Ananworanich J; HIV-NAT 113 Study Group. Prasitsuebsai W, et al. Among authors: chokephaibulkit k. Pediatr Infect Dis J. 2017 Oct;36(10):967-972. doi: 10.1097/INF.0000000000001638. Pediatr Infect Dis J. 2017. PMID: 28520611
Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
Anugulruengkitt S, Cressey TR, Suntarattiwong P, Ounchanum P, Srirompotong U, Jantarabenjakul W, Sophonphan J, Tawon Y, Punnahitanon S, Pancharoen C, Chokephaibulkit K, Puthanakit T; CIPHER_AEPEP Study Team. Anugulruengkitt S, et al. Among authors: chokephaibulkit k. Pediatr Infect Dis J. 2019 Feb;38(2):152-156. doi: 10.1097/INF.0000000000002195. Pediatr Infect Dis J. 2019. PMID: 30204660
Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
Anugulruengkitt S, Suntarattiwong P, Ounchanum P, Srirompotong U, Jantarabenjakul W, Sophonphan J, Punnahitanon S, Pancharoen C, Cressey TR, Chokephaibulkit K, Puthanakit T; CIPHER_AEPEP study team. Anugulruengkitt S, et al. Among authors: chokephaibulkit k. Pediatr Infect Dis J. 2019 Oct;38(10):1045-1050. doi: 10.1097/INF.0000000000002426. Pediatr Infect Dis J. 2019. PMID: 31365477
333 results